Conformationally-flexible benzamide analogues as dopamine D3 and σ2 receptor ligands
- 14 November 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (1) , 195-202
- https://doi.org/10.1016/j.bmcl.2003.09.083
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Synthesis of 2-(5-Bromo-2,3-dimethoxyphenyl)-5-(aminomethyl)-1H-pyrrole analogues and their binding affinities for dopamine D2, D3, and D4 receptorsBioorganic & Medicinal Chemistry, 2002
- Dopamine D3 Receptor Ligands with Antagonist PropertiesChemBioChem, 2002
- Interactive SAR Studies: Rational Discovery of Super-Potent and Highly Selective Dopamine D3 Receptor Antagonists and Partial AgonistsJournal of Medicinal Chemistry, 2002
- Design and Synthesis of [(2,3-Dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as Novel Ligands Selective for the Dopamine D3Receptor SubtypeJournal of Medicinal Chemistry, 2001
- Synthesis and Structure−Activity Relationships of Naphthamides as Dopamine D3 Receptor LigandsJournal of Medicinal Chemistry, 2001
- Distribution of Dopamine D3 Receptor Expressing Neurons in the Human Forebrain Comparison with D2 Receptor Expressing NeuronsNeuropsychopharmacology, 1999
- Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's diseaseMovement Disorders, 1998
- Mesolimbic Dopamine D3 Receptors and Use of Antipsychotics in Patients With SchizophreniaArchives of General Psychiatry, 1997
- 4-bromo-1-methoxy-N-[2-(4-aryl-1-piperazinyl)ethyl]-2-naphthalenecarboxamides: Selective dopamine D3 receptor partial agonistsBioorganic & Medicinal Chemistry Letters, 1996
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973